Cancer drug design and discovery Stephen Neidle.
Publication details: Boston Academic Press 2008Description: xv, 473 p., [27] p. of plates ill. (some col.) 27 cmISBN: 9780123694485; 0123694485Subject(s): Antineoplastic agents -- Development | Antineoplastic agents -- DesignNLM classification: QV269| Item type | Current library | Call number | Status | Date due | Barcode | Item holds |
|---|---|---|---|---|---|---|
| 西文圖書 | 怡仁綜合醫院圖書館 | QV269 (Browse shelf(Opens below)) | Available | E01275 |
Includes bibliographical references and index.
Pt. I Basic Principles.
Pt. II Methodology.
Pt. III Drugs in the Clinic.
Pt. IV New Agents.
Pt. V The Reality of Cancer Drugs in the Clinic.
The ultimate source of information on the design of new anticancer agents, emphasising small molecules, this newest work covers recent notable successes resulting from the human genome and cancer genomics projects. These advances have provided information on targets involved in specific cancers that are leading to effective medicines for at least some of the common solid tumours.
Unique sections explain the basic underlying principles of cancer drug development and provide a practical introduction to modern methods of drug design. Appealing to a broad audience, this is an excellent reference for translational researchers interested in cancer biology and medicine as well as students in pharmacy, pharmacology, or medicinal and biological chemistry, and clinicians taking oncology options.
There are no comments on this title.